Multiple Sclerosis and Related Disorders

Serum levels of 25-hydroxyvi- tamin D are a biomarker of future disease activity in patients with early relapsing–remitting multiple sclerosis (RRMS), and vitamin D supplementation

False positive tests engender extensive follow‐up testing, which in turn would produce considerable biopsy related risks and overdiagnosis, not to mention extra costs.. Were

From delivery to 6 months postpartum, there was a clear association between weight loss and lower prevalence of UI among women who were continent and as well as those among those

Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: results from the global Phase 4 Teri-PRO study

2.4 | Recovery and survival of platelets Following completion of the in vitro study, an indepen- dent, non-randomized, open-label in vivo study was per- formed using

The pooling procedure shown in Figure 1A illustrates that 21 relapsing-remitting multiple sclerosis (RRMS) patients and 21 neurological controls with other neurological diseases

Western firms engaging with social development in this envir- onment found themselves in a paradox: support the wishes of the ethnic Rakhine and help only the majority (as national fi

At the 12 months follow-up assessment, the number of patients with abnormal test results was significantly reduced to 16 patients (27.6%, p = 0.01), while 22 patients (37.9%, p =